Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation
E. A. Thim, L. E. Petricca, A. S. Mathew, F. Rivera-Escalera, M. R. Elliott, T. N. Bullock, R. J. Price
Abstract
BackgroundBoiling histotripsy (BH), a mechanical focused ultrasound ablation strategy, can elicit intriguing signatures of anti-tumor immunity. However, the influence of BH on dendritic cell function is unknown, compromising our ability to optimally combine BH with immunotherapies to control metastatic disease. MethodsBH was applied using a sparse scan (1 mm spacing between sonications) protocol to B16F10-ZsGreen melanoma in bilateral and unilateral settings. Ipsilateral and contralateral tumor growth was measured. Flow cytometry was used to track ZsGreen antigen and assess how BH drives dendritic cell behavior. ResultsBH monotherapy elicited ipsilateral and abscopal tumor control in this highly aggressive model. Tumor antigen presence in immune cells in the tumor-draining lymph nodes (TDLNs) was [~]3-fold greater at 24h after BH, but this abated by 96h. B cells, macrophages, monocytes, granulocytes, and both conventional dendritic cell subsets (i.e. cDC1s and cDC2s) acquired markedly more antigen with BH. BH drove activation of both cDC subsets, with activation being dependent upon tumor antigen acquisition. Our data also suggest that BH-liberated tumor antigen is complexed with damage-associated molecular patterns (DAMPs) and that cDCs do not traffic to the TDLN with antigen. Rather, they acquire antigen as it flows through afferent lymph vessels into the TDLN. ConclusionWhen applied with a sparse scan protocol, BH monotherapy elicits abscopal melanoma control and shapes dendritic cell function through several previously unappreciated mechanisms. These results offer new insight into how to best combine BH with immunotherapies for the treatment of metastatic melanoma. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/552844v2_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@a486d4org.highwire.dtl.DTLVardef@190041forg.highwire.dtl.DTLVardef@1febf36org.highwire.dtl.DTLVardef@1bb7f8f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory
Zehra E.F. Demir, AeRyon Kim, … Natasha Sheybani·Journal for ImmunoTherapy of CancerPeer-reviewed·Aug 1, 2026
- Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine model
Natalia L. Antonides-Jensen, Muskan Singh, … Sonia L. Hernandez·CancersPeer-reviewed·Apr 15, 2026
- Fractional Laser Treatment Boosts Systemic Anti-Tumor Immunity in Combination with OX40 Agonist and PD-1 Blockade
M. Kawakubo, J. Glahn, … D. Manstein·bioRxiv·Nov 29, 2021
- BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration--Implications for Combination Immunotherapy
Rui Quan, Hefa Huang, … Long Gu·bioRxiv·Nov 5, 2026
- Ultrasound Activated Nanobubbles Induce Durable Systemic Antitumor Immunity
Anubhuti Bhalotia, Pinunta Nittayacharn, … Efstathios Karathanasis·bioRxiv·Mar 27, 2026
- Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans
Aya Ludin, Georgia L. Stirtz, … Leonard Ira Zon·CellPeer-reviewed·Oct 17, 2025